<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="zh" lang="zh">
<head>
<title>国际非霍奇金淋巴瘤预后指数</title>
<link href="medcalcstyles.css" type="text/css" rel="stylesheet" />
<meta name="description" content="Medical Calculators, Criteria Sets and Decision Trees" />
<meta name="keywords" content="heme onc, prognosis, medcalc3000, medical, education, criteria, treecalc, decision, tree, medicine, clinical, medcalc, 3000, mdcalc, medicalc, medmath, clinicalc, clincalc, online, clinical" /> 
<meta name="author" content="Foundation Internet Services, LLC" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=no" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
</head>
<body class="medCalcBody">
<div id="mc3k">

<script language="JavaScript1.1" type="text/javascript">
/* <![CDATA[ */


var curelement;

function togCB(thisid){
thischeckbox = document.getElementById(thisid);
if (thischeckbox.checked){ thischeckbox.checked = false; }
else { thischeckbox.checked = true; }
IPINHL_fx();
}

function setRB(thisid){
document.getElementById(thisid).checked = true;
IPINHL_fx();
}


/* ]]> */
</script>


<script language="JavaScript1.1" type="text/javascript">
/* <![CDATA[ */







var calctxt = '';
var xmltxt = '';
var xmlresult = '';
var htmtxt = '';
var postNow = false;
var printing = false;
var rbchk = false;


function IPINHL_fx() {
with(document.IPINHL_form){

Score = 0.0;
doCalc = true;

if (cc1.checked){
Score = Score + 1;
}
if (cc2.checked){
Score = Score + 1;
}
if (cc3.checked){
Score = Score + 1;
}
if (cc4.checked){
Score = Score + 1;
}
rbchk = false;
if (cc5[0].checked){
rbchk = true; Score = Score + 0; 
}
if (cc5[1].checked){
rbchk = true; Score = Score + 0; 
}
if (cc5[2].checked){
rbchk = true; Score = Score + 1; 
}
if (cc5[3].checked){
rbchk = true; Score = Score + 1; 
}
if (cc5[4].checked){
rbchk = true; Score = Score + 1; 
}
if (!rbchk) doCalc = false;
if (doCalc){
cctotal.value = Score;
if (cctotal.value == 'NaN') cctotal.value = '';
}
else{
Score = null;
cctotal.value = '';
if (typeof rrclr == 'function') { rrclr(); };
document.IPINHL_form.cctotal.value = '';
}




if (doCalc){
rrclr();
if (( Score >= 0) && ( Score <= 1)){ document.getElementById('rr1_1').bgColor = '#8ab2be';
}
if (( Score >= 2) && ( Score <= 2)){ document.getElementById('rr1_2').bgColor = '#8ab2be';
}
if (( Score >= 3) && ( Score <= 3)){ document.getElementById('rr1_3').bgColor = '#8ab2be';
}
if (( Score >= 4) && ( Score <= 5)){ document.getElementById('rr1_4').bgColor = '#8ab2be';
}
if ((Score >= 0) && (Score <= 1)){ document.getElementById('rr2_5').bgColor = '#8ab2be';
}
if ((Score >= 2) && (Score <= 2)){ document.getElementById('rr2_6').bgColor = '#8ab2be';
}
if ((Score >= 3) && (Score <= 3)){ document.getElementById('rr2_7').bgColor = '#8ab2be';
}
if ((Score >= 4) && (Score <= 5)){ document.getElementById('rr2_8').bgColor = '#8ab2be';
}


}
}
}




function rrclr(){
document.getElementById('rr1_1').bgColor = '';
document.getElementById('rr1_2').bgColor = '';
document.getElementById('rr1_3').bgColor = '';
document.getElementById('rr1_4').bgColor = '';
document.getElementById('rr2_5').bgColor = '';
document.getElementById('rr2_6').bgColor = '';
document.getElementById('rr2_7').bgColor = '';
document.getElementById('rr2_8').bgColor = '';
}




/* ]]> */
</script>



<form name="IPINHL_form" id="IPINHL_form" action="" onsubmit="return false;" onreset="rrclr(); ">
<table width="100%" cellpadding="4" cellspacing="0" summary="EBMcalc Table">
<tr><td class="medCalcTitleBox" width="1%"><br /></td>
<td class="medCalcTitleBox">
<span class="medCalcFontTitleBox">

 
国际非霍奇金淋巴瘤预后指数
</span></td></tr></table><br />&nbsp;<br />
<div id="calc_main">
<div id="calc_input">
<center>
<table cellpadding="3" cellspacing="0" summary="EBMcalc Table">
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" id="togel1" name="cc1" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="togCB('togel1');" >年龄&gt;60 周岁 (1 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" id="togel2" name="cc2" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="togCB('togel2');" >血清乳酸脱氢酶浓度高于正常值 (1 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" id="togel3" name="cc3" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="togCB('togel3');" >Ann Arbor III 或 IV 期 (1 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right" valign="top"><input type="checkbox" id="togel4" name="cc4" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="togCB('togel4');" >结节外病灶多于一处 (1 分)</span></td></tr>
<tr><td colspan="3" align="left"><span class="medCalcFontCCTabBold">ECOG 体能量表 </span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" id="togel5" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="setRB('togel5');"> 体能状态 0：完全正常；无体能限制 (0 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" id="togel6" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="setRB('togel6');"> 体能状态 1：不能从事较重的体力活动；能自由走动和从事轻体活动 (0 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" id="togel7" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="setRB('togel7');"> 体能状态 2：能生活自理但丧失任何工作能力。日间不少于&gt;一半时间可以起床活动 (1 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" id="togel8" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="setRB('togel8');"> 体能状态 3：生活仅能部分自理；&gt;日间一半时间卧床或坐轮椅 (1 分)</span></td></tr>
<tr><td width="20"><br /></td>
<td align="right"><input type="radio" id="togel9" name="cc5" onclick="IPINHL_fx();" /></td>
<td align="left"><span class="medCalcFontOneClick" onclick="setRB('togel9');"> 体能状态 4：完全丧失活动能力；不能自理；必须卧床或坐轮椅 (1 分)</span></td></tr>

</table>

</center>
</div>
<br />&nbsp;<br />
<div id="calc_result">
<span class="medCalcFontCCTabBold">
标准分数总和:
</span>
<input type="text" size="6" name="cctotal" onfocus="blur();" /><br />&nbsp;<br />
<center><input type="reset" name="reset" value="重设表格" />    </center>
<br />&nbsp;<br />
<div id="rr1_tag">
<table width="100%" cellpadding="4" cellspacing="0" summary="EBMcalc Table">
<tr><td class="medCalcTitleBox" width="1%"><br /></td>
<td class="medCalcTitleBox">
<span class="medCalcFontTitleBox">


2031 例侵袭性非霍奇金淋巴瘤患者经蒽环类药物为主的治疗方案治疗后， 不包括利妥昔单抗，5年总体生存率（OS）和完全有效（CR）率分别如下：
</span></td></tr></table><br />&nbsp;<br />
</div>
<center>
<table border="1" cellpadding="4" cellspacing="0" summary="RRTable">
<tr id="rr1_1"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">0 - 1 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne">低风险 5 年总体生存率 73% 和完全有效率 87%</span></td></tr>
<tr id="rr1_2"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">2 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> 中低风险为 5 年总体生存率 51% 和完全有效率 67%</span></td></tr>
<tr id="rr1_3"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">3 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> 中高风险为 5 年总体生存率 43% 和完全有效率 55%</span></td></tr>
<tr id="rr1_4"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">4 - 5 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> 高风险为 5 年总体生存率 26% 和完全有效率 44%</span></td></tr>

</table>
</center>
<br />&nbsp;<br />
<br />&nbsp;<br />
<div id="rr2_tag">
<table width="100%" cellpadding="4" cellspacing="0" summary="EBMcalc Table">
<tr><td class="medCalcTitleBox" width="1%"><br /></td>
<td class="medCalcTitleBox">
<span class="medCalcFontTitleBox">


1063 例经利妥昔单抗加 CHOP/CHOP 类似化疗的患者，3 年无事件生存率（EFS）、 无进展生存率（PFS）及总体生存率（OS）如下：
</span></td></tr></table><br />&nbsp;<br />
</div>
<center>
<table border="1" cellpadding="4" cellspacing="0" summary="RRTable">
<tr id="rr2_5"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">0 - 1 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 81%、 PFS 87% 及 OS 91%</span></td></tr>
<tr id="rr2_6"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">2 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 69%、 PFS 75% 及 OS 81%</span></td></tr>
<tr id="rr2_7"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">3 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 53%、 PFS 59% 及 OS 65%</span></td></tr>
<tr id="rr2_8"><td align="right" style="border-right: 0px;" nowrap="nowrap"><span class="medCalcFontOneBold">4 - 5 分数:</span></td>
<td align="left" style="border-left: 0px;"><span class="medCalcFontOne"> EFS 50%、 PFS 50% 及 OS 59%</span></td></tr>

</table>
</center>
<br />&nbsp;<br />

</div>
</div>

<div id="calc_notes">
<span class="medCalcFontOneBold">注意</span>
<ul class="medCalcFontOne">
<li><b>ECOG</b>: 东部肿瘤协作组。</li>
<li><b>NHL</b>: 非霍奇金淋巴瘤。</li>


</ul>
</div>

<br />&nbsp;<br />

<div id="calc_refs">
<span class="medCalcFontRef"><b>参考</b></span>
<ol>
<li><span class="medCalcFontRef">The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive  non-Hodgkin's lymphoma. <i>N Engl J Med</i>. 1993; 329:987. PubMed ID: 8141877 <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/8141877"><img border="0" src="pubmed.gif" align="top" alt="PubMed Logo" /></a> </span></li>
<li><span class="medCalcFontRef">Ziepert M, Hasenclever D, Kuhnt E, et al. Standard International prognostic index remains a valid  predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era. <i> J Clin Oncol</i>. 2010; 28:2373. Epub 2010 Apr 12. Erratum in: J Clin Oncol 2011; 29:779. PubMed ID: 20385988 <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/20385988"><img border="0" src="pubmed.gif" align="top" alt="PubMed Logo" /></a> </span></li>
<li><span class="medCalcFontRef">Oken MM, Creech RH, Tormey DC, et al, Eastern Cooperative Oncology Group, Robert Comis M.D., Group Chair.  Toxicity and response criteria of the Eastern Cooperative Oncology Group. <i> Am J Clin Oncol</i>. 1982; 5:649. PubMed ID: 7165009 <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pubmed/7165009"><img border="0" src="pubmed.gif" align="top" alt="PubMed Logo" /></a> </span></li>

</ol>
</div>

 
</form>
<div id="calc_disclaimer"> <br />&nbsp;<br /><center><br />&nbsp;<br />&nbsp;<br /><table bgcolor="#cccccc" cellpadding="16" summary="EBMcalc Table"><tr><td><center><span class="medCalcFontTwo"><br />&nbsp;<br /><b><u>法律条款及免责声明</u></b></span></center><br />&nbsp;<br /><span class="medCalcFontTwo">EBMcalc 系统所包含和生成的所有信息仅用于教育目的。这些信息不应被用于任何健康问题或疾病的诊断或治疗。
<b>这些信息不能以任何方式取代临床判断或指导个体患者的治疗。
</b><a href="disclaimer-zh.htm" target="_blank">按一下此处了解完整条款和免责声明。</a></span><br />&nbsp;<br /><center><span class="medCalcFontTwo">EBMcalc is Copyright &#169; 1998-2022 Foundation Internet Services &nbsp;&nbsp; [Build 267312 v22.3]</span></center></td></tr></table></center>
</div><script language="JavaScript1.1" type="text/javascript">
/* <![CDATA[ */







function loadQueryParams(thisqs){
if (thisqs) alert('Data panel values cannot be transferred to this calculator.');
return;
}


/* ]]> */
</script>





</div>
</body>
</html>


<!-- 1662471498 //-->
